Elravie RE2O Fine

Note: the package insert and traceability sticker have been removed from the box; the serial number could be erased. The blister is sealed – sterility and quality are unchanged.

Application Areas of Elravie Re2O Fine

Elravie Re2O Fine is a professional-use ECM skin-repair product developed specifically for areas where the skin is thin, sensitive, or requires especially precise application. It is the finer-particle version of Elravie Re2O, with an average particle size of approximately 50 μm.

Unlike conventional hyaluronic acid skin boosters that mainly provide hydration, or biostimulating products that encourage the skin to produce new collagen, Elravie Re2O Fine supplies components of the extracellular matrix directly. The extracellular matrix, commonly known as ECM, is the natural structural framework that supports the skin and contains collagen, elastin, hyaluronic acid, and other important structural substances.

The fine particle structure allows the material to be distributed more evenly within delicate skin layers. This makes the product particularly suitable for professional treatments targeting:

• The under-eye and eye-contour area
• Fine lines around the eyes
• Thin or crepey-looking skin
• Fine lines around the mouth
• Neck lines and delicate neck skin
• Loss of skin elasticity and density
• Uneven or rough skin texture
• Areas requiring precise and natural-looking correction

Elravie Re2O Fine is designed primarily to support skin quality and structural recovery rather than create the pronounced volume associated with traditional dermal fillers.

Strengths of Elravie Re2O Fine

The principal advantage of Elravie Re2O Fine is its human-derived extracellular matrix composition. The product is manufactured from human acellular dermal matrix, or hADM. During processing, cellular components are removed while the natural structural framework of the dermal tissue is preserved.

This remaining matrix contains components naturally found in human skin, including collagen, elastin, hyaluronic acid, and supportive proteins. By supplementing the dermal environment with these structural elements, the product is intended to support the reconstruction and functional recovery of damaged or weakened skin tissue.

Elravie Re2O Fine offers several important characteristics:

• Human-derived ECM rather than animal collagen
• Fine particles averaging approximately 50 μm
• More precise distribution in thin and delicate skin
• Support for skin elasticity, density, and texture
• Natural-looking improvement without excessive volumization
• Particulate human acellular dermal matrix with high biocompatibility
• Suitable for focused treatment of sensitive facial areas

According to the manufacturer, the processing technology removes cells and other components associated with immune responses. The manufacturing process is also performed without the use of surfactants, helping preserve the natural extracellular matrix structure.

Compared with standard Elravie Re2O, the Fine version contains a smaller amount of material and uses finer particles. Standard Re2O is generally selected for broader treatment areas, while Re2O Fine is designed for more targeted work on thin skin, particularly around the eyes, mouth, and neck.

Who Is This Product For?

Elravie Re2O Fine is intended for licensed aesthetic and medical professionals looking for an ECM-based product for delicate treatment areas. It may be considered for clients concerned about fine lines, reduced elasticity, thin skin, uneven texture, or age-related weakening of the dermal structure.

The product may be especially relevant when the objective is to improve the overall quality and structural condition of the skin without creating an obviously filled or over-volumized appearance.

Elravie Re2O Fine contains material derived from donated human skin tissue. All cellular material is removed during processing, leaving a purified, cell-free extracellular matrix. Clients must be informed of the human-tissue origin before treatment.

This is a professional-use product and must not be self-administered. Product preparation, treatment suitability, application method, quantity, and treatment areas must be determined by a properly qualified and licensed practitioner. Availability and permitted use may differ by country, and purchasers are responsible for confirming the applicable regulations in their jurisdiction.